<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T03:09:11Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/12584" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/12584</identifier><datestamp>2025-10-24T08:51:50Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>com_2072_378071</setSpec><setSpec>col_2072_378092</setSpec><setSpec>col_2072_378097</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:DIDLInfo>
      <dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2025-10-24T08:51:50Z</dcterms:created>
   </d:DIDLInfo>
   <d:Item id="hdl_11351_12584">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:11351/12584</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>Current perspectives in the management of sepsis and septic shock</dc:title>
               <dc:creator>Ruiz Sanmartin, Adolfo</dc:creator>
               <dc:creator>Bajaña Mindiolaza, Ivan Rene</dc:creator>
               <dc:creator>Bastidas, Juliana</dc:creator>
               <dc:creator>Lopez-Martinez, Rocio</dc:creator>
               <dc:creator>Franco-Jarava, Clara</dc:creator>
               <dc:creator>Chiscano Camon, Luis</dc:creator>
               <dc:creator>González-López, Juan José</dc:creator>
               <dc:creator>Riera del Brio, Jordi</dc:creator>
               <dc:creator>Ruiz-Rodriguez, Juan Carlos</dc:creator>
               <dc:creator>Ferrer, Ricard</dc:creator>
               <dc:creator>Larrosa, María Nieves</dc:creator>
               <dc:creator>Nuvials, Xavier</dc:creator>
               <dc:subject>Septicèmia - Tractament</dc:subject>
               <dc:subject>Xoc sèptic - Tractament</dc:subject>
               <dc:subject>Medicina personalitzada</dc:subject>
               <dc:subject>Marcadors bioquímics</dc:subject>
               <dc:subject>Fenotip</dc:subject>
               <dc:subject>DISEASES::Bacterial Infections and Mycoses::Infection::Sepsis::Shock, Septic</dc:subject>
               <dc:subject>Other subheadings::Other subheadings::/therapy</dc:subject>
               <dc:subject>DISEASES::Bacterial Infections and Mycoses::Infection::Sepsis</dc:subject>
               <dc:subject>Other subheadings::Other subheadings::/therapy</dc:subject>
               <dc:subject>CHEMICALS AND DRUGS::Biological Factors::Biomarkers</dc:subject>
               <dc:subject>PHENOMENA AND PROCESSES::Genetic Phenomena::Phenotype</dc:subject>
               <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Precision Medicine</dc:subject>
               <dc:subject>ENFERMEDADES::infecciones bacterianas y micosis::infección::sepsis::choque séptico</dc:subject>
               <dc:subject>Otros calificadores::Otros calificadores::/terapia</dc:subject>
               <dc:subject>ENFERMEDADES::infecciones bacterianas y micosis::infección::sepsis</dc:subject>
               <dc:subject>Otros calificadores::Otros calificadores::/terapia</dc:subject>
               <dc:subject>COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores</dc:subject>
               <dc:subject>FENÓMENOS Y PROCESOS::fenómenos genéticos::fenotipo</dc:subject>
               <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::medicina de precisión</dc:subject>
               <dc:description>Precision medicine; Sepsis phenotypes; Septic shock</dc:description>
               <dc:description>Medicina de precisió; Fenotips de sèpsia; Xoc sèptic</dc:description>
               <dc:description>Medicina de precisión; Fenotipos de sepsis; Shock séptico</dc:description>
               <dc:description>Within patients with sepsis, there exists significant heterogeneity, and while all patients should receive conventional therapy, there are subgroups of patients who may benefit from specific therapies, often referred to as rescue therapies. Therefore, the identification of these specific patient subgroups is crucial and lays the groundwork for the application of precision medicine based on the development of targeted interventions. Over the years, efforts have been made to categorize sepsis into different subtypes based on clinical characteristics, biomarkers, or underlying mechanisms. For example, sepsis can be stratified into different phenotypes based on the predominant dysregulated host response. These phenotypes can range from hyperinflammatory states to immunosuppressive states and even mixed phenotypes. Each phenotype may require different therapeutic approaches to improve patient outcomes. Rescue strategies for septic shock may encompass various interventions, such as immunomodulatory therapies, extracorporeal support (e.g., ECMO), or therapies targeted at specific molecular or cellular pathways involved in the pathophysiology of sepsis. In recent years, there has been growing interest in precision medicine approaches to sepsis and phenotype identification. Precision medicine aims to tailor treatments to each individual patient based on their unique characteristics and disease mechanisms.</dc:description>
               <dc:date>2025-10-24T08:51:50Z</dc:date>
               <dc:date>2025-10-24T08:51:50Z</dc:date>
               <dc:date>2025-02-11T12:42:31Z</dc:date>
               <dc:date>2025-02-11T12:42:31Z</dc:date>
               <dc:date>2024-08-15</dc:date>
               <dc:type>info:eu-repo/semantics/article</dc:type>
               <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
               <dc:identifier>http://hdl.handle.net/11351/12584</dc:identifier>
               <dc:relation>Frontiers in Medicine;11</dc:relation>
               <dc:relation>https://doi.org/10.3389/fmed.2024.1431791</dc:relation>
               <dc:rights>Attribution 4.0 International</dc:rights>
               <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
               <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
               <dc:publisher>Frontiers Media</dc:publisher>
               <dc:source>Scientia</dc:source>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>